Literature DB >> 7888202

Zidovudine induces the expression of cellular resistance affecting its antiviral activity.

F Dianzani1, G Antonelli, O Turriziani, E Riva, E Simeoni, C Signoretti, S Strosselli, M Cianfriglia.   

Abstract

We have previously shown that multidrug-resistant cells expressing the multidrug transporter P-glycoprotein are less sensitive to the antiviral activity of AZT. Subsequently, we addressed the question whether AZT itself is able to induce cellular resistance to the drug. Indeed, CEM cells propagated in the presence of increasing concentrations of AZT become resistant to the antigrowth and antiviral activity of AZT but do not express detectable level of P-glycoprotein. Sensitivity of these cells to other compounds, such as vinblastine, vincristine, ddI, and ddC remained unchanged, indicating that, in contrast to P-glycoprotein-positive cells, AZT-induced resistance is specific for AZT. Interestingly, in AZT-induced resistant cells the intracellular accumulation of AZT and exogenous deoxythymidine, as well as thymidine kinase activity, are significantly reduced when compared with the parental cell line. Our findings show that AZT itself may directly induce the expression of cellular mechanisms leading to the acquisition of specific cellular resistance that can affect its antiviral activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7888202     DOI: 10.1089/aid.1994.10.1471

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  6 in total

1.  May the drug transporter P glycoprotein affect the antiviral activity of human immunodeficiency virus type 1 proteinase inhibitors?

Authors:  O Turriziani; P Di Marco; G Antonelli; F Dianzani
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  Use of viral resistance patterns to antiretroviral drugs in optimising selection of drug combinations and sequences.

Authors:  G J Moyle
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546

Review 3.  Antiretroviral therapy for HIV infection. A knowledge-based approach to drug selection and use.

Authors:  G J Moyle; B G Gazzard; D A Cooper; J Gatell
Journal:  Drugs       Date:  1998-03       Impact factor: 9.546

4.  Impaired 2',3'-dideoxy-3'-thiacytidine accumulation in T-lymphoblastoid cells as a mechanism of acquired resistance independent of multidrug resistant protein 4 with a possible role for ATP-binding cassette C11.

Authors:  O Turriziani; J D Schuetz; F Focher; C Scagnolari; J Sampath; M Adachi; F Bambacioni; E Riva; G Antonelli
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

5.  Immunomodulatory effect of zidovudine (ZDV) on cytotoxic T lymphocytes previously exposed to ZDV.

Authors:  Sabine Francke; Charles G Orosz; Jason Hsu; Lawrence E Mathes
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

Review 6.  Managing resistance to anti-HIV drugs: an important consideration for effective disease management.

Authors:  A M Vandamme; K Van Laethem; E De Clercq
Journal:  Drugs       Date:  1999-03       Impact factor: 11.431

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.